BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Strandvik B, O Neal WK, Ali MA, Hammar U. Low linoleic and high docosahexaenoic acids in a severe phenotype of transgenic cystic fibrosis mice. Exp Biol Med (Maywood) 2018;243:496-503. [PMID: 29513100 DOI: 10.1177/1535370218758605] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Drzymała-Czyż S, Krzyżanowska-Jankowska P, Dziedzic K, Lisowska A, Kurek S, Goździk-Spychalska J, Kononets V, Woźniak D, Mądry E, Walkowiak J. Severe Genotype, Pancreatic Insufficiency and Low Dose of Pancreatic Enzymes Associate with Abnormal Serum Sterol Profile in Cystic Fibrosis. Biomolecules 2021;11:313. [PMID: 33669566 DOI: 10.3390/biom11020313] [Reference Citation Analysis]
2 Nowak JK, Wykrętowicz A, Mądry E, Krauze T, Drzymała-Czyż S, Krzyżanowska-Jankowska P, Sobkowiak P, Schneider A, Goździk-Spychalska J, Kurek S, Kononets V, Kashirskaya N, Lisowska A, Walkowiak J. Preclinical atherosclerosis in cystic fibrosis: Two distinct presentations are related to pancreatic status. J Cyst Fibros 2021:S1569-1993(21)01294-7. [PMID: 34253491 DOI: 10.1016/j.jcf.2021.06.010] [Reference Citation Analysis]
3 Philippe R, Urbach V. Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis. Int J Mol Sci 2018;19:E2865. [PMID: 30241412 DOI: 10.3390/ijms19102865] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]